Evidence map›Paper›PMID 32754871›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2021

Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.

Serge-Daniel Le Bon, Nathalie Pisarski, Justine Verbeke, Léa Prunier, Gaëtan Cavelier, Marie-Paule Thill, Alexandra Rodriguez, Didier Dequanter, Jérôme R Lechien, Olivier Le Bon and 2 more

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Systematic review and meta-analysis of olfactory and gustatory dysfunction in COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Assessment of olfactory recovery after COVID-19: cross-sectional study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Olfactory Function and Olfactory Disorders.Laryngo- rhino- otologie · 2023
    Article
  18. [Interpretation of the 2021 American Academy of Allergy, Asthma and Immunology expert consensus on the treatment of postinfectious olfactory dysfunction].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Serge-Daniel Le BonDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium. sergelebon@gmail.com.ORCID http://orcid.org/0000-0001-7943-3404
Nathalie PisarskiDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Justine VerbekeDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Léa PrunierDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Gaëtan CavelierDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Marie-Paule ThillDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Alexandra RodriguezDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Didier DequanterDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Jérôme R LechienDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.
Olivier Le BonDepartment of Psychiatry and Laboratory of Psychiatric Research (ULB 266), Cliniques universitaires de Bruxelles, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Thomas HummelSmell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, Dresden, Germany.
Mihaela HoroiDepartment of Otorhinolaryngology, CHU Saint-Pierre, 129 Boulevard de Waterloo, 1000, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the evolution of chemosensation via extended psychophysical testing in patients who suffered from sudden chemosensory loss due to coronavirus disease 2019 (COVID-19). Additionally, this study sought to determine whether odor threshold testing provided additional information on olfactory loss due to COVID-19 compared to the more common odor identification testing.

methodsProspective cohort study of patients with sudden chemosensory loss since February 2020 and confirmed COVID-19 infection via RT-PCR or serology testing. Olfactory function was tested extensively using the "Sniffin Sticks" test battery. In addition, we screened gustatory perception and nasal cooling sensations using psychophysical tests.

resultsSeventy-two patients completed the study. After a mean of 37 days, 37% of patients showed olfactory dysfunction, 7% were dysgeusic, and 48% showed signs of low sensitivity for cooling sensation. A longer duration of anosmia before smell improvement was correlated with lower olfactory function at 5 weeks. Odor threshold detection was more affected by COVID-19 compared to odor identification.

conclusionFive weeks after developing sudden chemosensory loss due to COVID-19, a high proportion of patients were dysosmic and showed signs of low nasal cooling sensitivity, whereas most of them had normal taste function. SARS-CoV-2 affected mainly odor thresholds, possibly suggesting that the major cause of loss of smell lies at the level of the olfactory neuroepithelium, rather than in the central nervous system.

Indexed as

AdultAnosmiaCOVID-19FemaleHumansMaleMiddle AgedOdorantsOlfaction DisordersProspective StudiesSARS-CoV-2SmellSymptom AssessmentChemosensory lossCOVID-19Psychophysical testSARS-CoV-2

Identifiers

PMID32754871
PMCPMC7402072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.